JPS5865217A - 治療製剤及びその製法 - Google Patents

治療製剤及びその製法

Info

Publication number
JPS5865217A
JPS5865217A JP57143510A JP14351082A JPS5865217A JP S5865217 A JPS5865217 A JP S5865217A JP 57143510 A JP57143510 A JP 57143510A JP 14351082 A JP14351082 A JP 14351082A JP S5865217 A JPS5865217 A JP S5865217A
Authority
JP
Japan
Prior art keywords
compound
formula
cis
salt
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57143510A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6360005B2 (enExample
Inventor
スボラド・シユトルク
ビクトル・バウエル
ルデク・ベネス
ミロス・テイチ−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Czech Academy of Sciences
Original Assignee
Czech Academy of Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Czech Academy of Sciences filed Critical Czech Academy of Sciences
Publication of JPS5865217A publication Critical patent/JPS5865217A/ja
Publication of JPS6360005B2 publication Critical patent/JPS6360005B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP57143510A 1981-08-20 1982-08-20 治療製剤及びその製法 Granted JPS5865217A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS6254-81 1981-08-20
CS625481A CS229067B1 (en) 1981-08-20 1981-08-20 Medicinal preparation with antiarhythmic and supporting effect applied with hypoxia,and method of preparing active substance thereof

Publications (2)

Publication Number Publication Date
JPS5865217A true JPS5865217A (ja) 1983-04-18
JPS6360005B2 JPS6360005B2 (enExample) 1988-11-22

Family

ID=5409157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57143510A Granted JPS5865217A (ja) 1981-08-20 1982-08-20 治療製剤及びその製法

Country Status (7)

Country Link
JP (1) JPS5865217A (enExample)
BE (1) BE894148A (enExample)
CH (1) CH651754A5 (enExample)
CS (1) CS229067B1 (enExample)
DE (1) DE3231088A1 (enExample)
NL (1) NL8203226A (enExample)
SE (1) SE461831B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009524676A (ja) * 2006-01-25 2009-07-02 メディベイション ニューロロジー， インコーポレイテッド 精神分裂病を治療するための方法および組成物
JP2010535220A (ja) * 2007-08-01 2010-11-18 メディベイション ニューロロジー， インコーポレイテッド 抗精神病用の併用療法剤を使用する統合失調症の治療のための方法および組成物
CN102827167A (zh) * 2006-02-24 2012-12-19 雅培制药有限公司 八氢-吡咯并[3,4-b]吡咯衍生物及其作为组胺-3 受体配体的用途

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101809021B (zh) 2007-09-11 2013-04-24 雅培制药有限公司 八氢-吡咯并[3,4-b]吡咯n-氧化物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657254A (en) * 1969-10-31 1972-04-18 Nikolai Konstantinovich Barkov 3 6-dimethyl-1 2 3 4 4a 9a-hexahydro-gamma-carboline dihydrochloride
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CES.FYSIOL=1977 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009524676A (ja) * 2006-01-25 2009-07-02 メディベイション ニューロロジー， インコーポレイテッド 精神分裂病を治療するための方法および組成物
CN102827167A (zh) * 2006-02-24 2012-12-19 雅培制药有限公司 八氢-吡咯并[3,4-b]吡咯衍生物及其作为组胺-3 受体配体的用途
JP2010535220A (ja) * 2007-08-01 2010-11-18 メディベイション ニューロロジー， インコーポレイテッド 抗精神病用の併用療法剤を使用する統合失調症の治療のための方法および組成物

Also Published As

Publication number Publication date
BE894148A (fr) 1982-12-16
NL8203226A (nl) 1983-03-16
SE8204693L (sv) 1983-02-21
CH651754A5 (de) 1985-10-15
CS229067B1 (en) 1984-04-16
SE8204693D0 (sv) 1982-08-13
DE3231088A1 (de) 1983-03-10
JPS6360005B2 (enExample) 1988-11-22
DE3231088C2 (enExample) 1990-02-22
SE461831B (sv) 1990-04-02

Similar Documents

Publication Publication Date Title
SU1272989A3 (ru) Способ получени диазабицикло (3,3,1) нонанов
US3773939A (en) N-arallyl-n'-aralkyl piperazine pharmaceutical compositions
US3509164A (en) Derivatives of 1-(p-hydroxyphenyl)-2-(4-benzyl-1-piperidino)-(alkanols)
LEONARD The use of diphenylhydantoin (Dilantin) sodium in the treatment of ventricular tachycardia
US4299838A (en) Tryptophan derivatives having an increased effect on the central nervous system
US4604394A (en) Antiarrhythmic compositions and method
SU1609453A3 (ru) Способ получени производных гидантоина
Gilbert et al. Influence of sympathomimetic pressor drugs on arrhythmias caused by multiple stimuli
JPS6360005B2 (enExample)
JPH01268634A (ja) 心臓不整脈治療用医薬の製造でのキノリジンとキノリジノン誘導体の用途
CA1088944A (en) Nitric ester of n-(2-hydroxyethyl)nicotinamide and a process for the preparation of same
JPS6043351B2 (ja) 老人医学的薬剤の製法
DE2755016C2 (enExample)
RU2180583C1 (ru) Лекарственный препарат для лечения различных форм нарушения ритма сердца
JPS61500437A (ja) ｎ−プロパノ−ルアミン誘導体のエ−テル
US2995491A (en) Method of treating cardiac arrhythmia with 1-(2-diethylaminoethyl)-5-ethyl-5-phenylbarbituric acid
US3436458A (en) Antispasmodic and gastric antisecretory compositions containing rho-phenylphenacyl derivatives of 1-hyoscyamine and d,1-tropylatropine
US3849570A (en) Method of treating cardiac arrhythmia with 2-(2'-diethylaminoethyl)-3-phenyl-phthalimidine and its salts
RU1208774C (ru) Дихлоргидрат 9-метил-12- [2-(4-метилпиперазино)этил] -6,7-дигидробенз [2`,3`] оксепино [4,5-b] индола, обладающий антиаритмической активностью
SAKAI et al. Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias
US4148898A (en) N-oxy-ajmaline and the use thereof in treating cardiovascular disorders
US3840666A (en) Anti-arrhythmic quaternary salt compositions and methods of use
CA1076605A (en) 1-(trialkylamino)-3-(phenylphenoxy)-2-propanol quarternary salts
JPH0374233B2 (enExample)
SU956463A1 (ru) Четвертичные аммониевые производные анилидов аминоуксусной кислоты,обладающие противоаритмической активностью